This content requires a premium subscription.
Please log in or subscribe to continue.
SAGE Neuroscience and Neurology
GSJ: Thirty-Day Readmission Risk Factors Following Single-Level Transforaminal Lumbar Interbody Fusion (TLIF) for 4992 Patients From the ACS-NSQIP Database